TNSN03043A1 - 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof - Google Patents

2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
TNSN03043A1
TNSN03043A1 TNPCT/EP2002/000567A TNSN03043A TNSN03043A1 TN SN03043 A1 TNSN03043 A1 TN SN03043A1 TN SN03043 A TNSN03043 A TN SN03043A TN SN03043 A1 TNSN03043 A1 TN SN03043A1
Authority
TN
Tunisia
Prior art keywords
preparation
processes
pharmaceutical compositions
benzopyran derivatives
benzopyran
Prior art date
Application number
TNPCT/EP2002/000567A
Other languages
English (en)
Inventor
Maurizio Civelli
Elisabetta Galbiati
Gabriele Amari
Maurizio Delcanale
Elisabetta Armani
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01101521A external-priority patent/EP1229036B1/en
Priority claimed from EP01118682A external-priority patent/EP1281710A1/en
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of TNSN03043A1 publication Critical patent/TNSN03043A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
TNPCT/EP2002/000567A 2001-01-24 2003-07-08 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof TNSN03043A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01101521A EP1229036B1 (en) 2001-01-24 2001-01-24 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en) 2001-08-03 2001-08-03 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
TNSN03043A1 true TNSN03043A1 (en) 2005-12-23

Family

ID=26076450

Family Applications (1)

Application Number Title Priority Date Filing Date
TNPCT/EP2002/000567A TNSN03043A1 (en) 2001-01-24 2003-07-08 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Country Status (26)

Country Link
US (1) US6951883B2 (enExample)
EP (1) EP1355906B1 (enExample)
JP (1) JP4332349B2 (enExample)
CN (1) CN1261431C (enExample)
AT (1) ATE286894T1 (enExample)
AU (1) AU2002237282B2 (enExample)
BR (1) BR0207066A (enExample)
CA (1) CA2435775A1 (enExample)
CZ (1) CZ20032014A3 (enExample)
DE (1) DE60202590T2 (enExample)
DK (1) DK1355906T3 (enExample)
DZ (1) DZ3459A1 (enExample)
EA (1) EA006158B1 (enExample)
ES (1) ES2236485T3 (enExample)
HU (1) HUP0401018A3 (enExample)
IL (2) IL157065A0 (enExample)
MA (1) MA26982A1 (enExample)
MX (1) MXPA03006505A (enExample)
NO (1) NO327808B1 (enExample)
NZ (1) NZ527144A (enExample)
PL (1) PL365062A1 (enExample)
PT (1) PT1355906E (enExample)
SI (1) SI1355906T1 (enExample)
SK (1) SK287086B6 (enExample)
TN (1) TNSN03043A1 (enExample)
WO (1) WO2002059113A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4913056B2 (ja) * 2004-09-21 2012-04-11 マーシャル エドワーズ,インコーポレーテッド 置換クロマン誘導体、医薬品、および治療における使用
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ,インク. 化合物
ATE532777T1 (de) * 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
AU2005201855B2 (en) * 2004-09-21 2012-03-29 Marshall Edwards, Inc. Chroman derived compounds and formulations thereof for use in therapy
EP1809618B1 (en) * 2004-09-21 2013-07-17 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
CN101444499B (zh) * 2007-11-26 2012-12-05 湘北威尔曼制药股份有限公司 一种化合物及其组合物的新用途
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
CN107427003B (zh) 2015-02-02 2023-01-31 梅制药公司 联合治疗
JP6946430B2 (ja) * 2016-11-17 2021-10-06 サノフイSanofi 新規の置換n−(3−フルオロプロピル)−ピロリジン化合物、それを製造するための方法、およびその治療的使用
EP3681495A4 (en) * 2017-09-15 2021-06-02 Nyrada Pty Limited TREATMENT OF EXCITOTOXICITY
CN112225716A (zh) * 2020-10-30 2021-01-15 陕西嘉禾生物科技股份有限公司 一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374245A (en) * 1964-04-01 1968-03-19 Ciba Geigy Corp Unsaturated oxacycles
DE1518002C3 (de) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en) 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
IL129623A0 (en) 1996-10-28 2000-02-29 Novo Nordisk As Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
CN1120162C (zh) * 1996-12-13 2003-09-03 中外制药株式会社 新的苯并吡喃衍生物
KR20000001793A (ko) * 1998-06-13 2000-01-15 이경하 신규한 벤조피란 또는 티오벤조피란 유도체
AU765159B2 (en) 1998-12-30 2003-09-11 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors

Also Published As

Publication number Publication date
PL365062A1 (en) 2004-12-27
PT1355906E (pt) 2005-05-31
WO2002059113A1 (en) 2002-08-01
NO20033318D0 (no) 2003-07-23
CA2435775A1 (en) 2002-08-01
SI1355906T1 (en) 2005-06-30
HUP0401018A3 (en) 2007-05-29
JP2004517151A (ja) 2004-06-10
US20040106595A1 (en) 2004-06-03
NZ527144A (en) 2005-03-24
MA26982A1 (fr) 2004-12-20
EA006158B1 (ru) 2005-10-27
EP1355906A1 (en) 2003-10-29
CN1261431C (zh) 2006-06-28
DE60202590T2 (de) 2005-12-29
US6951883B2 (en) 2005-10-04
JP4332349B2 (ja) 2009-09-16
DK1355906T3 (da) 2005-05-30
ATE286894T1 (de) 2005-01-15
EA200300727A1 (ru) 2004-02-26
DE60202590D1 (de) 2005-02-17
SK9392003A3 (en) 2003-12-02
SK287086B6 (sk) 2009-11-05
MXPA03006505A (es) 2004-04-21
IL157065A0 (en) 2004-02-08
HUP0401018A2 (hu) 2004-09-28
CN1487934A (zh) 2004-04-07
CZ20032014A3 (cs) 2003-12-17
EP1355906B1 (en) 2005-01-12
BR0207066A (pt) 2004-03-30
AU2002237282B2 (en) 2007-02-15
NO327808B1 (no) 2009-09-28
HK1060558A1 (en) 2004-08-13
IL157065A (en) 2010-05-17
NO20033318L (no) 2003-09-24
ES2236485T3 (es) 2005-07-16
DZ3459A1 (fr) 2002-08-01

Similar Documents

Publication Publication Date Title
HU228253B1 (en) Substituted cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
IL161857A0 (en) Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
PL367682A1 (en) Dolastatin 10 derivatives
WO2000072837A3 (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
IL161582A0 (en) Use of oxindole hydrazide derivatives for the preparation of pharmaceutical compositions, certain such new derivatives and their preparation
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
TNSN03043A1 (en) 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
HUP0400154A3 (en) Heterocondesated benzoxazepine and benzoxathiazepine derivatives, their use and pharmaceutical compositions containing them
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
AP2001002369A0 (en) Pharmaceutical complex.
DE60108354D1 (de) 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen
SI1176148T1 (en) Benzothiadiazine derivatives, processes for their preparation and pharmaceutical compositions containing them
SI1297835T1 (sl) Derivati benzo(b)pirano(3,2-h)akridin-7-ona, postopek za njihovo pripravo in farmacevtski sestavki,ki jih vsebujejo
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
IL156861A0 (en) Pyrrole derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
CA2420056A1 (en) 1-amino-alkylcyclohexanes as trypanocidal agents
HUP0402149A3 (en) Water-soluble phenylpyridazine derivatives, their use and pharmaceutical compositions containing the same
ZA200110073B (en) 14β-H-Sterols, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments.
UY27406A1 (es) Derivados de 2h-1-benzopirano, procesos para su preparación y composiciones farmacéuticas que los contienen
WO2002100342A3 (en) (s, s'), (s, r')-amphetaminil, compositions and uses thereof